Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight
Rhea-AI Summary
Inspire Medical Systems (NYSE: INSP) announced that its management team will participate in the Wells Fargo 2026 MedTech Innovation Spotlight on Friday, June 26, 2026. The company is scheduled to present at 10:00 a.m. Eastern Time, with a live webcast and two-week replay available.
Positive
- None.
Negative
- None.
News Market Reaction – INSP
In the Jun 12 session, INSP gained 0.61%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 04 | Earnings release | Negative | -12.0% | Q1 2026 results with lowered full-year revenue guidance and headwinds. |
| Apr 29 | Conference appearance | Neutral | -3.1% | Announcement of presentation at BofA Securities 2026 Healthcare Conference. |
| Apr 06 | Earnings date set | Neutral | -1.6% | Scheduling of Q1 2026 earnings release and conference call details. |
| Mar 03 | Conference appearance | Neutral | +1.5% | Planned presentation at KeyBanc Capital Markets Healthcare Forum. |
| Feb 11 | Earnings release | Positive | -12.6% | Strong 4Q25 and FY 2025 results with updated 2026 revenue guidance. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings and neutral conference announcements frequently saw negative or mixed next-day moves, with only one of the last five news events aligning positively with its apparent tone.
Over the last several months, INSP has reported mixed-to-strong fundamentals alongside guidance resets and multiple investor events. The Q1 2026 results on May 4 showed modest revenue growth but narrowed and lower 2026 guidance, followed by a -12.02% move. Earlier, robust 4Q25 and full-year 2025 results also preceded a -12.55% reaction. In contrast, routine conference participation headlines in March and late April produced smaller, mixed price changes. Today’s Wells Fargo MedTech Spotlight participation fits that pattern of standard investor-relations outreach.
Key Terms
obstructive sleep apnea medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, June 12, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will participate in the Wells Fargo 2026 MedTech Innovation Spotlight on Friday, June 26, 2026.
Inspire is scheduled to speak at 10:00 a.m. Eastern Time. The presentation will be accessible via a live webcast here.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
